drugset / Trial / NCT02872090

Effects of Long Acting Bronchodilators on CARDiac Autonomic Control in Chronic Obstructive Pulmonary Disease (COPD)

NCT02872090

Phase 4 Completed 42 enrolled Centre Hospitalier Universitaire de Besancon
RandomizedCrossoverQuadruple-blindTreatment

Summary

The aim of this interventional, randomized, double-blind, monocentric, cross-over study is to quantify the possible deleterious effect on the cardiac autonomic nervous system control of two long-acting anticholinergic bronchodilatators (tiotropium and glycopyrronium) and one beta-2 agonist long-acting bronchodilatator (indacaterol ) in patients with mild COPD.

Timeline

Start
2016-03
Primary completion
2021-06-01
Completion
2021-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Glycopyrronium Unknown Inhaled
Subject Indacaterol Other / unclassified Inhaled
Subject Tiotropium Other / unclassified Inhaled